EFFECT OF OVINE PROLACTIN ADMINISTRATION ON HYPOTHALAMIC VASOACTIVE-INTESTINAL-PEPTIDE (VIP), GONADOTROPIN-RELEASING HORMONE-I AND HORMONE-II CONTENT, AND ANTERIOR-PITUITARY VIP RECEPTORS IN LAYING TURKEY HENS
I. Rozenboim et al., EFFECT OF OVINE PROLACTIN ADMINISTRATION ON HYPOTHALAMIC VASOACTIVE-INTESTINAL-PEPTIDE (VIP), GONADOTROPIN-RELEASING HORMONE-I AND HORMONE-II CONTENT, AND ANTERIOR-PITUITARY VIP RECEPTORS IN LAYING TURKEY HENS, Biology of reproduction, 48(6), 1993, pp. 1246-1250
The effect of ovine prolactin (oPRL) administration to laying and incu
bating turkey hens was studied. In experiment one, five treatment grou
ps (n = 6) of laying hens received injections of vehicle or oPRL (4 mg
/bird/day) for 2, 4, 8, or 14 days. Hypothalamic vasoactive intestinal
peptide (VIP) content decreased to its lowest level (p < 0.05) by Day
2 of oPRL injection. Serum turkey PRL decreased by Day 8 of injection
, reaching nadir by Day 14. Similar to the decline in hypothalamic VIP
content, the maximal decline in the number of anterior pituitary VIP
binding sites was achieved by Day 2 of oPRL administration. Hypothalam
ic GnRH-1 content decreased after 2 days of oPRL injection and remaine
d low through Day 14 of the experiment. GnRH-II levels declined with t
ime, reaching significantly lower levels after 8 days of injections, a
nd remained low through Day 14. Plasma LH levels also declined (p < 0.
05) after Day 14 of oPRL administration. In experiment 2, two groups (
n = 6) of incubating birds were used: controls receiving injections of
vehicle only and birds receiving injections of oPRL (4 mg/bird/day) f
or 10 days. Exogenous oPRL had no effect on hypothalamic VIP, GnRH-I o
r II, anterior pituitary VIP binding sites, or plasma turkey PRL or LH
. The findings suggest that in laying hens, PRL inhibits its own secre
tion by acting on both the hypothalamus and the anterior pituitary; th
is phenomenon does not occur in incubating birds. Furthermore, we prov
ide evidence that PRL acts centrally to reduce LH levels by reducing G
nRH levels in the hypothalamus.